Characteristics of the analysed study population
| Characteristic | n | % |
|---|---|---|
| Patients | 650 | 100.0 |
| Female | 433 | 66.6 |
| Target drugs | 1333 | |
| Mean | SD (range) | |
| Age, years | 81 | 6.7 (70–101) |
| eGFR, ml/min/1.73 m2 | 63.3 | 17.0 (13–>95) |
| Number of drugs | 5.8 | 2.8 (1–17) |
| Number of target drugs | 2 | 1.1 (1–7) |
| Patients prescribed target drugs by therapeutic group | n | % |
| Blood glucose-lowering drugs | 156 | 24.0 |
| Cardiac glycosides digoxin | 73 | 11.2 |
| Low-ceiling diuretics thiazides | 259 | 39.8 |
| High-ceiling diuretics | 164 | 25.2 |
| Potassium sparing diuretics | 49 | 7.5 |
| Diuretics combinations | 46 | 7.1 |
| Beta-blocker sotalol | 33 | 5.1 |
| Beta-blockers atenolol/bisoprolol | 31 | 4.8 |
| RAS inhibitors | 224 | 5.1 |
eGFR = estimated glomerular filtration rate. RAS renin–angiotensin system. SD = standard deviation